
We talk with Dr. Laura VanBlargen, a staff scientist, about her work to develop and characterize new monoclonal antibody-based therapies for SARS-CoV-2.
Version: 20241125

We talk with Dr. Laura VanBlargen, a staff scientist, about her work to develop and characterize new monoclonal antibody-based therapies for SARS-CoV-2.
No comments yet. Be the first to say something!